SLNO
Soleno Therapeutics Inc
NASDAQ: SLNO · HEALTHCARE · BIOTECHNOLOGY
$52.78
+0.04% today
Updated 2026-04-29
Market cap
$2.73B
P/E ratio
135.33
P/S ratio
14.34x
EPS (TTM)
$0.39
Dividend yield
—
52W range
$29 – $90
Volume
3.8M
Soleno Therapeutics Inc (SLNO) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$52.78
12-Month target
$2.65
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 11.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.